TECX

Tectonic Therapeutic, Inc.

5 catalysts on file

TECX

Tectonic Therapeutic, Inc.

Phase 1 AI-extracted

TX45

Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (PH-HFrEF)

324d ago Oct 1, 2025

SEC 8-K verified 2mo ago

TECX

Tectonic Therapeutic, Inc.

AdCom AI-extracted

TX2100

Hereditary Hemorrhagic Telangiectasia (HHT)

201d ago Feb 1, 2026

SEC 8-K verified 2mo ago

TECX

Tectonic Therapeutic, Inc.

Phase 1 AI-extracted

TX2100

Hereditary Hemorrhagic Telangiectasia (HHT)

T-minus 40 days ~ Sep 30, 2026

SEC 8-K verified 2mo ago

TECX

Tectonic Therapeutic, Inc.

Phase 2 AI-extracted

TX45

Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (PH-HFpEF)

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

TECX

Tectonic Therapeutic, Inc.

Catalyst AI-extracted

TX2100

Hereditary Hemorrhagic Telangiectasia (HHT)

T-minus 133 days ~ Jan 1, 2027

SEC 8-K verified 2mo ago